SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 63 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $199,762 | -95.0% | 52,847 | -91.1% | 0.00% | -90.0% |
| Q2 2023 | $3,964,939 | +443.9% | 591,782 | +428.5% | 0.01% | +400.0% |
| Q1 2023 | $728,996 | -15.5% | 111,981 | +10.7% | 0.00% | -33.3% |
| Q4 2022 | $862,775 | +39.8% | 101,146 | -13.4% | 0.00% | +50.0% |
| Q3 2022 | $617,000 | -24.8% | 116,800 | -39.6% | 0.00% | -33.3% |
| Q2 2022 | $820,000 | -41.8% | 193,500 | -51.8% | 0.00% | -25.0% |
| Q1 2022 | $1,408,000 | -46.0% | 401,176 | +2.4% | 0.00% | -33.3% |
| Q4 2021 | $2,609,000 | +73.6% | 391,684 | +160.1% | 0.01% | +100.0% |
| Q3 2021 | $1,503,000 | – | 150,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $10,085,000 | 3.26% |
| K2 PRINCIPAL FUND, L.P. | 3,247,533 | $16,890,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,045,234 | $5,519,000 | 1.09% |
| Orbimed Advisors | 8,740,887 | $46,152,000 | 0.86% |
| Rubric Capital Management LP | 2,695,170 | $14,230,000 | 0.72% |
| Prosight Management, LP | 196,257 | $1,036,000 | 0.56% |
| Nantahala Capital Management | 1,249,863 | $6,599,000 | 0.43% |
| Oasis Management Co Ltd. | 317,662 | $1,677,000 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 409,463 | $2,162,000 | 0.26% |
| APOGEM CAPITAL LLC | 13,793 | $73,000 | 0.07% |